The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

South Carolina Could Declare Measles Outbreak Over by April 26, Health Official Says

South Carolina could declare its ongoing measles ⁠outbreak over by April 26 if no additional infections are reported, the state's ⁠top epidemiologist said during a briefing...

A Ubiquitous Alcohol Emerges as Allergen of 2026

Benzyl alcohol, though generally safe, can be a stealth cause of allergic dermatitis through a variety of exposures.

Allergic Rhinitis May Worsen Asthma Risk in CRS

Individuals with chronic rhinosinusitis face an elevated risk of developing new-onset asthma and subsequent exacerbations, and concurrent allergic rhinitis increases the risk.

EU Chemicals Agency Backs Ban on PFAS 'Forever Chemicals'

The European Chemicals Agency on Thursday recommended a broad EU-wide ban on PFAS, or "forever chemicals," with some ⁠exemptions.

Survey Examines Current Practice in Skin of Color Clinics

Clinics dedicated to treating patients with skin of color are increasingly common, but a survey suggests they are addressing this need with limited or no institutional support.

Can Better Risk Communication Improve Patient Decisions?

Limited numeracy affects how patients interpret risk and treatment benefits, highlighting the need for clear, structured numerical communication to support shared decision-making.

Todays Updates

Novel Psychedelic Promising on Resistant Depression

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.

Biocomputer From Human Neurons Plays Doom, Raises Ethics

A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.

EMA OKs Two Treatments for Small Cell Lung Cancer

Both drugs increase overall and progression-free survival.

Todays Updates

Novel Psychedelic Promising on Resistant Depression

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.

Biocomputer From Human Neurons Plays Doom, Raises Ethics

A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.

EMA OKs Two Treatments for Small Cell Lung Cancer

Both drugs increase overall and progression-free survival.

Latest News

South Carolina could declare its ongoing measles ⁠outbreak over by April 26 if no additional infections are reported, the state's ⁠top epidemiologist said during a briefing...

Benzyl alcohol, though generally safe, can be a stealth cause of allergic dermatitis through a variety of exposures.

Individuals with chronic rhinosinusitis face an elevated risk of developing new-onset asthma and subsequent exacerbations, and concurrent allergic rhinitis increases the risk.

The European Chemicals Agency on Thursday recommended a broad EU-wide ban on PFAS, or "forever chemicals," with some ⁠exemptions.

Clinics dedicated to treating patients with skin of color are increasingly common, but a survey suggests they are addressing this need with limited or no institutional support.

Limited numeracy affects how patients interpret risk and treatment benefits, highlighting the need for clear, structured numerical communication to support shared decision-making.

News All Time

Olmesartan-Induced Sprue Causes Diarrhea in a Woman

Recurrent severe diarrhea with acute kidney injury after drug reinitiation highlights a rare but serious enteropathy linked to antihypertensive therapy.

Victoria Pilots PA Program for Harm Reduction Workers

Harm reduction workers who bring lived experience to harm reduction programs may themselves need support for a substance use disorder.

Adrenaline Fails to Reverse Histamine-Induced Hypotension

Standard intramuscular adrenaline fails to reverse histamine‑induced hypotension in healthy adults, new research shows.

Data Support Ruxolitinib’s Safety for Eczema in Children

A long-term analysis offers reassurance to users of the topical treatment recently approved for children down to age 2.

Time to Rethink Early Morning In-Hospital Blood Draws?

Delaying in-hospital blood draws by just 2 hours helped sleep quality and quantity, researchers find. Now, some hospitals are considering a change to traditional timing.

Liver Enzyme Guides Prognosis in CKD Patients on Dialysis

Among patients with CKD, serum total ALP and its liver, bone, and intestinal fractions increase with disease severity, and liver ALP is associated with mortality in those undergoing haemodialysis.

‘I HATE YOU’ and Other Things People Say to Their Doctors

Patient rudeness, in-person or on the portal, is more common than ever, and data now show it’s taking a toll on quality care.

Medical Accuracy of 'The Pitt'

The cast and creators of HBO Max's 'The Pitt' explain how they get the medicine right, and why it matters.

COVID Shots in Pregnancy Protect Infants’ First 6 Months

The research adds important evidence for clinicians counseling pregnant patients.

Barzolvolimab Shows Persistent Benefits for CSU

Patients maintain their improvements off treatment, even after clearance of barzolvolimab, investigators report.

Specialty Care in Crisis in British Columbia

Long wait times for an appointment with a specialist and for treatment after the referral are putting lives at risk, experts say.

Review Finds Benefits of Biotic Therapy for Acne

‘It is theorized that probiotics improve skin barrier hydration through multiple mechanisms, including modulation of the skin microbiome,’ according to the authors.

FDA Withdraws Proposal to Prohibit Minors From Tanning Beds

‘Restricting teens’ access to indoor tanning and informing the public about the dangers of indoor tanning are critical to preventing skin cancer,’ AAD President Susan C. Taylor, MD, said.

Will Healthcare Data Become Easier to Access in Canada?

The Canadian government introduced legislation to make it easier for patients and physicians to access and share electronic medical records and other types of health data.

Hidradenitis Suppurativa Linked to Increased Cancer Risk

A meta-analysis shows that hidradenitis suppurativa is associated with a higher risk for multiple cancer subtypes.

Risk Tool Flags Infection Risk After High‑Dose Steroids

A novel scoring system can effectively stratify patients with autoimmune inflammatory rheumatic diseases into high- and low-risk groups for serious infections after high-dose glucocorticoid therapy.

Recommended News For You

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

Preventable pediatric cancer mortality surges in areas of armed conflict, exceeding rates in non-conflict regions

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

Obesity-associated cancers may be on the rise in Puerto Rico

combating racial discrimination in next-generation breast cancer screening.

Muscular strength and good physical fitness linked to lower risk of death in people with cancer

Recommended Articles For You

The Benefits and Risks of Transurethral Resection of Bladder Tumor  

Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk 

Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy 

The Truth About Marijuana and Its Effect on Mental Health  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma

2.

Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer

3.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

4.

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

5.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

1.

The New Era of Oncology: Key Updates and Clinical Insights

2.

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment

3.

ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring

4.

The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025

5.

Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

2.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

3.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

5.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot